26
20
Brain Tumor Reports

Volume 10 Number 4
April 2010

Home > Publications > Brain Tumor Reports > Volume 10, Year 2010 > Number 4, April°


Contents



Etiology & Pathogenesis



Schwartzbaum JA, Huang K, Lawler S, Ding B, Yu J, Chiocca EA.
Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma
Neuro Oncol. 2010 Apr;12(4):320-7. Epub 2009 Dec 24
  Abstract

Sonoda Y, Yokosawa M, Saito R, Kanamori M, Yamashita Y, Kumabe T, Watanabe M, Tominaga T.
O (6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma
Int J Clin Oncol. 2010 Mar 16;. [Epub ahead of print]
  Abstract


Integrative Medicine



Bangaru ML, Chen S, Woodliff J, Kansra S.
Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells
Anticancer Res. 2010 Feb;30(2):499-504
  Abstract

González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Alvarez-García V, Sánchez-Barceló EJ, Cos S.
Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells
Oncol Rep. 2010 Apr;23(4):1173-8.
  Abstract

Puri T, Goyal S, Julka PK, Nair O, Sharma DN, Rath GK.
Lycopene in treatment of high-grade gliomas: A pilot study
Neurol India. 2010 Jan-Feb;58(1):20-3
  Abstract |   Full Text


Overall Management



Birbilis TA, Matis GK, Eleftheriadis SG, Theodoropoulou EN, Sivridis E.
Spinal Metastasis of Glioblastoma Multiforme: An Uncommon Suspect?
Spine (Phila Pa 1976). 2010 Feb 26;. [Epub ahead of print]
  Abstract

Hernáiz Driever P, von Hornstein S, Pietsch T, Kortmann R, Warmuth-Metz M, Emser A, Gnekow AK.
Natural history and management of low-grade glioma in NF-1 children
J Neurooncol. 2010 Mar 30;. [Epub ahead of print]
  Abstract |   Full Text |   Reprint


Prognosis



Graesslin O, Abdulkarim BS, Coutant C, Huguet F, Gabos Z, Hsu L, Marpeau O, Uzan S, Pusztai L, Strom EA, Hortobagyi GN, Rouzier R, Ibrahim NK.
Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer
J Clin Oncol. 2010 Mar 22;. [Epub ahead of print]
  Abstract

Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, Scheie D, Vik A, Meling TR.
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
Acta Neurol Scand. 2010 Mar 18;. [Epub ahead of print]
  Abstract

Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, Quayle K, Goumnerova LC, Irons MB, Ullrich NJ.
Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1
Pediatr Blood Cancer. 2010 Mar 22;. [Epub ahead of print]
  Abstract

Milano MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN.
Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma
Int J Radiat Oncol Biol Phys. 2010 Mar 6;. [Epub ahead of print]
  Abstract

Neervoort FW, Van Ouwerkerk WJ, Folkersma H, Kaspers GJ, Vandertop WP.
Surgical morbidity and mortality of pediatric brain tumors: a single center audit
Childs Nerv Syst. 2010 Mar 5;. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Olmez I, Donahue BR, Butler JS, Huang Y, Rubin P, Xu Y.
Clinical outcomes in extracranial tumor sites and unusual toxicities with concurrent whole brain radiation (WBRT) and Erlotinib treatment in patients with non-small cell lung cancer (NSCLC) with brain metastasis
Lung Cancer. 2010 Mar 5;. [Epub ahead of print]
  Abstract

Serowka K, Chiu Y, Gonzalez I, Gilles F, McComb G, Krieger M, Dhall G, Britt B, Ji L, Sposto R, Finlay JL.
Central nervous system (CNS) tumors in the first six months of life: the Children's Hospital Los Angeles experience, 1979-2005
Pediatr Hematol Oncol. 2010 Mar;27(2):90-102
  Abstract

Sheehan JP, Yen CP, Nguyen J, Rainey JA, Dassoulas K, Schlesinger DJ.
Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery
J Neurosurg. 2010 Mar 12;. [Epub ahead of print]
  Abstract

Tendulkar RD, Pai Panandiker AS, Wu S, Kun LE, Broniscer A, Sanford RA, Merchant TE.
Irradiation of Pediatric High-Grade Spinal Cord Tumors
Int J Radiat Oncol Biol Phys. 2010 Mar 24;. [Epub ahead of print]
  Abstract

Tu Y, Lu J, Fu J, Cao Y, Fu G, Kang R, Tian X, Wang B.
Over-expression of Neuroepithelial-transforming Protein 1 Confers Poor Prognosis of Patients with Gliomas
Jpn J Clin Oncol. 2010 Mar 18;. [Epub ahead of print]
  Abstract


Stem Cells



Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R.
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
Cell Cycle. 2010 Mar 18;9(6). [Epub ahead of print]
  Abstract |   Reprint

Pistollato F, Abbadi S, Rampazzo E, Persano L, Puppa AD, Frasson C, Sarto E, Scienza R, D'Avella D, Basso G
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Stem Cells. 2010 Mar 22. [Epub ahead of print]
  Abstract


Treatment


Clinical Investigations



Agha CA, Ibrahim S, Hassan A, Elias DA, Fathallah-Shaykh HM.
Bevacizumab is active as a single agent against recurrent malignant gliomas
Anticancer Res. 2010 Feb;30(2):609-11
  Abstract

Arslan C, Dizdar O, Altundag K.
Systemic treatment in breast-cancer patients with brain metastasis
Expert Opin Pharmacother. 2010 Mar 29;. [Epub ahead of print]
  Abstract

Bai B, Yuan ZY, Liu DG, Teng XY, Wang SS
Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases
Ai Zheng. 2010 Apr;29(4):413-9
  Abstract |   Reprint

Chiang KL, Chang KP, Lee YY, Huang PI, Hsu TR, Chen YW, Chang FC, Wong TT.
Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution
Childs Nerv Syst. 2010 Mar 10;. [Epub ahead of print]
  Abstract

Fabi A, Metro G, Vidiri A, Lanzetta G, Carosi M, Telera S, Maschio M, Russillo M, Sperduti I, Carapella CM, Cognetti F, Pace A.
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
J Neurooncol. 2010 Mar 30;. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Iwamoto FM, Lamborn KR, Robins HI, Mehta MP, Chang SM, Butowski NA, Deangelis LM, Abrey LE, Zhang WT, Prados MD, Fine HA.
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
Neuro Oncol. 2010 Mar 3;. [Epub ahead of print]
  Abstract

Li L, Quang TS, Gracely EJ, Kim JH, Emrich JG, Yaeger TE, Jenrette JM, Cohen SC, Black P, Brady LW.
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme
J Neurosurg. 2010 Mar 26;. [Epub ahead of print]
  Abstract

Natelson EA, Pyatt D.
Temozolomide-induced myelodysplasia
Adv Hematol. 2010;2010:760402. Published online 2010 March 4
  Abstract |   Full Text |   Reprint

Nuutinen T, Suuronen T, Kauppinen A, Salminen A.
Valproic acid stimulates clusterin expression in human astrocytes: Implications for Alzheimer's disease
Neurosci Lett. 2010 Mar 20;. [Epub ahead of print]
  Abstract

Pellegatta S, Poliani PL, Stucchi E, Corno D, Colombo CA, Orzan F, Ravanini M, Finocchiaro G.
Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment
Neuro Oncol. 2010 Apr;12(4):377-88. Epub 2010 Jan 6
  Abstract

Perry JR, Bélanger K, Mason WP, Fulton D, Kavan P, Easaw J, Shields C, Kirby S, Macdonald DR, Eisenstat DD, Thiessen B, Forsyth P, Pouliot JF.
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
J Clin Oncol. 2010 Mar 22;. [Epub ahead of print]
  Abstract

Phuphanich S, Supko JG, Carson KA, Grossman SA, Burt Nabors L, Mikkelsen T, Lesser G, Rosenfeld S, Desideri S, Olson JJ.
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
J Neurooncol. 2010 Mar 8;. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Rosati A, Buttolo L, Stefini R, Todeschini A, Cenzato M, Padovani A.
Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study
Arch Neurol. 2010 Mar;67(3):343-6.
  Abstract

Wen PY
Therapy for Recurrent High-Grade Gliomas: Does Continuous Dose-Intense Temozolomide Have a Role?
J Clin Oncol. 2010 Mar 22. [Epub ahead of print]
  Abstract |   Full Text |   Reprint

Seiz M, Nölte I, Pechlivanis I, Freyschlag CF, Schmieder K, Vajkoczy P, Tuettenberg J.
Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib
Neurosurg Rev. 2010 Mar 20;. [Epub ahead of print]
  Abstract


Patients & Caregivers



Strangman D, Oliver K
IBTA E-News April 2010
International Brain Tumour Alliance

Strangman D, Oliver K
IBTA E-News March 2010
International Brain Tumour Alliance